Genghis Lloyd-Harris, Partner, Abingworth Management Ltd
Simon Buckingham, President, Global Corporate and Business Development, Actelion Pharmaceuticals
Anders Hedegaard, President and CEO, Bavarian Nordic A/S
Markus Hosang, General Partner, BioMedPartners
Stephanie Léouzon, Senior Advisor, Credit Suisse
Wolfgang Renner, CEO, Cytos AG
Dimitri Dimitriou, CEO, DyoDelta Biosciences
Marion Jung, Principal, Earlybird Venture Capital
Olivier Litzka, Partner, Edmond de Rothschild Investment Partners
Eric Le Royer, President & CEO, Endosense
Matthew Walls, CEO, Epistem Ltd
Beth Jacobs, Managing Partner, Excellentia Global Partners
Nigel Sheail, Head Corporate Business Development, F. Hoffmann-La Roche Ltd.
Arthur Franken, Partner, Gilde Healthcare Partners
Shelagh Wilson, Vice President, Head of European CEEDD, GSK
Carlton Brown, CEO, Immune Targeting Systems
Stan Yakatan, Chairman, Katan Associates
Thomas Klaue, CFO, Medigene
Margaret Beer, Senior Director and Head, Licensing and External Research, Europe, Merck & Co
Dr Guillaume Vignon, Associate Director Negotiation, Early Stage Licensing, Merck Serono
Roel Bulthius, Head of Merck Serono Ventures, Merck Serono Ventures
Anthony Hartley, Executive Director, Morgan Stanley
David Chiswell, CEO, Nabriva Therapeutics AG
Esteban Pombo Villar, Head of Strategic Alliance Management EU, Novartis Pharma
Knut Sturmhoefel, Head Alliance Management, Global Business Development & Licensing, Novartis Pharma
Naveed Siddiqi, Partner, Nomura Phase4 Ventures
Riccardo Manetti, Head, S&E Research & Technology Licensing, Novartis Vaccines & Diagnostics
Markus Goebel, Managing Director, Novartis Venture Funds
Ulrik Spork, Managing Partner, Novo A/S
Marcus Werner, Director International Licensing, Business Development, Nycomed
Peter Honig, Managing Director, PH Regulatory Medical Advisors
Fintan Walton, CEO, PharmaVentures Ltd
Carole Nuechterlein, Head of Venture Funds, Roche Venture Funds
Antoine Papiernik, Managing Partner, Sofinnova Partners
Paul Leijten, Senior Partnering Director, Teva Pharmaceuticals Europe
Alexandra Goll, General Partner, TVM Capital
Simon Turton, Managing Director Healthcare, Warburg Pincus LLC
Peter Llewellyn-Davies, CFO, Wilex AG